Tumor Biology

, Volume 35, Issue 11, pp 11415–11426 | Cite as

Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis

  • Zi-Wen Long
  • Jiang-Li Wang
  • Ya-Nong Wang
Research Article


Messenger RNA (mRNA) acts as template for protein synthesis. The matrix metalloproteinase-7 (MMP-7) protein and its mRNA expression have been suggested to be involved in the development of various diseases and cancers. We aimed to study associations between the MMP-7 protein and mRNA expression in gastric carcinoma (GC) patients. We searched in the Science Citation Index, the Cochrane Library, PubMed, Embase, CINAHL, Current Contents Index, and several Chinese databases. Studies were pooled and odds ratios and their corresponding 95 % confidence intervals were calculated. Subgroup analyses and publication bias detection were also conducted. Statistical analysis was performed via Version 12.0 STATA software. An updated meta-analysis based on 16 independent cohort studies was performed to investigate this association. The study suggests that significant differences in MMP-7 protein levels were observed in tumor–node–metastasis (TNM) I–II vs. III–IV (odds radio (OR) = 3.19, 95 % confidence interval (95%CI) = 1.59∼6.41, P = 0.001), in T1-2 vs. T3-4 invasive grade (OR = 1.82, 95%CI = 1.07∼3.12, P = 0.028), and in distant metastasis-positive vs. metastasis-negative samples (OR = 3.14, 95%CI = 1.05∼9.35, P = 0.040). Increased MMP-7 mRNA levels were found to be significantly correlated with invasive grade (T3-4 vs. T1-2: OR = 5.61, 95%CI = 2.64∼11.95, P < 0.001) and in the lymph node (LN) metastasis (positive vs. negative: OR = 7.08, 95%CI = 4.20∼11.93, P < 0.001) group. Country subgroup analysis yielded significantly different estimates in the protein expression of MMP-7 of all experimental groups. MMP-7 mRNA levels were increased in LN metastasis-positive GC in contrast to metastasis-negative in China and Korea (all P < 0.05); this was not shown in Japan (P > 0.05). Higher protein and mRNA levels of MMP-7 were statistically associated with aggressive LN metastasis, advanced TNM stage, and invasion in GC patients; MMP-7 can thus potentially serve as a useful biomarker in determining GC progression and prognosis.


MMP-7 Gastric carcinoma Meta-analysis 



We would like to acknowledge the reviewers for their helpful comments on this paper.

Conflict of interest



  1. 1.
    Fanelli MF, Chinen LT, Begnami MD, Costa Jr WL, Fregnami JH, Soares FA, et al. The influence of transforming growth factor-alpha, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer. Histopathology. 2012;61(2):153–61.PubMedCrossRefGoogle Scholar
  2. 2.
    Meng XY, Zhou CH, Ma J, Jiang C, Ji P. Expression of interleukin-17 and its clinical significance in gastric cancer patients. Med Oncol. 2012;29(5):3024–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Zhang X, Zheng L, Sun Y, Zhang X. Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population. Tumour Biol. 2014;35(2):1575–80.PubMedCrossRefGoogle Scholar
  4. 4.
    Okayama H, Kumamoto K, Saitou K, Hayase S, Kofunato Y, Sato Y, et al. CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. Oncol Rep. 2009;22(4):745–55.PubMedGoogle Scholar
  5. 5.
    Chen JQ, Zhan WH, He YL, Peng JS, Wang JP, Cai SR, et al. Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas. World J Gastroenterol. 2004;10(6):776–82.PubMedGoogle Scholar
  6. 6.
    Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, et al. Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer. Hepatogastroenterology. 2006;53(72):964–7.PubMedGoogle Scholar
  7. 7.
    Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagstrom J, et al. MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol. 2010;31(3):149–55.PubMedCrossRefGoogle Scholar
  8. 8.
    Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, et al. Association between IL-17A, −17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer. Int J Mol Med. 2010;25(3):471–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Kitoh T, Yanai H, Saitoh Y, Nakamura Y, Matsubara Y, Kitoh H, et al. Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer. J Gastroenterol. 2004;39(5):434–40.PubMedCrossRefGoogle Scholar
  10. 10.
    Swarnakar S, Paul S, Singh LP, Reiter RJ. Matrix metalloproteinases in health and disease: regulation by melatonin. J Pineal Res. 2011;50(1):8–20.PubMedCrossRefGoogle Scholar
  11. 11.
    Bauvois B. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta. 2012;1825(1):29–36.PubMedGoogle Scholar
  12. 12.
    Koskensalo S, Louhimo J, Nordling S, Hagstrom J, Haglund C. MMP-7 as a prognostic marker in colorectal cancer. Tumour Biol. 2011;32(2):259–64.PubMedCrossRefGoogle Scholar
  13. 13.
    Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 2010;20(3):161–8.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Achyut BR, Ghoshal UC, Moorchung N, Mittal B. Transforming growth factor-B1 and matrix metalloproteinase-7 promoter variants induce risk for Helicobacter pylori-associated gastric precancerous lesions. DNA Cell Biol. 2009;28(6):295–301.PubMedCrossRefGoogle Scholar
  15. 15.
    Lin MC, Wang FY, Kuo YH, Tang FY. Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells. J Agric Food Chem. 2011;59(20):11304–18.PubMedCrossRefGoogle Scholar
  16. 16.
    Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol. 2011;21(1):35–43.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Zhou JH, Zhang B, Kernstine KH, Zhong L. Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma. World J Gastroenterol. 2011;17(10):1373–8.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Koperek O, Aumayr K, Schindl M, Werba G, Soleiman A, Schoppmann S, et al. Phosphorylation of STAT3 correlates with HER2 status, but not with survival in pancreatic ductal adenocarcinoma. APMIS. 2014;122(6):476–81.PubMedCrossRefGoogle Scholar
  19. 19.
    Li Z, Zhang D, Zhang H, Miao Z, Tang Y, Sun G, et al. Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients. Tumour Biol. 2014;35(4):3463–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Sampieri CL, Leon-Cordoba K, Remes-Troche JM. Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers. J Cancer Res Ther. 2013;9(3):356–63.PubMedCrossRefGoogle Scholar
  21. 21.
    Shi M, Liu D, Duan H, Han C, Wei B, Qian L, et al. Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer. Mol Cancer. 2010;9:269.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Zhao H, Yang Z, Wang X, Zhang X, Wang M, Wang Y, et al. Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin. Exp Mol Med. 2012;44(11):633–41.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Kim H, He Y, Yang I, Zeng Y, Kim Y, Seo YW, et al. delta-Catenin promotes E-cadherin processing and activates beta-catenin-mediated signaling: implications on human prostate cancer progression. Biochim Biophys Acta. 2012;1822(4):509–21.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Yeh YC, Sheu BS, Cheng HC, Wang YL, Yang HB, Wu JJ. Elevated serum matrix metalloproteinase-3 and −7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival. Dig Dis Sci. 2010;55(6):1649–57.PubMedCrossRefGoogle Scholar
  25. 25.
    Lukaszewicz-Zajac M, Mroczko B, Szmitkowski M. Gastric cancer—the role of matrix metalloproteinases in tumor progression. Clin Chim Acta. 2011;412(19–20):1725–30.PubMedCrossRefGoogle Scholar
  26. 26.
    Lee KH, Shin SJ, Kim KO, Kim MK, Hyun MS, Kim TN, et al. Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma. Oncol Rep. 2006;16(4):823–30.PubMedGoogle Scholar
  27. 27.
    Zheng HC, Sun JM, Li XH, Yang XF, Zhang YC, Xin Y. Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma. Pathol Int. 2003;53(10):659–66.PubMedCrossRefGoogle Scholar
  28. 28.
    Panic N, Leoncini E, de Belvis G, Ricciardi W, Boccia S. Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS ONE. 2013;8(12):e83138.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Zintzaras E, Ioannidis JP. HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005;21(18):3672–3.PubMedCrossRefGoogle Scholar
  31. 31.
    Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28(2):123–37.PubMedCrossRefGoogle Scholar
  32. 32.
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.PubMedCrossRefGoogle Scholar
  33. 33.
    Song F, Gilbody S. Bias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysis. 471. 1998;316(7129).Google Scholar
  34. 34.
    Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676–80.PubMedCrossRefGoogle Scholar
  35. 35.
    Gencer S, Sen G, Dogusoy G, Belli AK, Paksoy M. Yazicioglu MB beta-catenin-independent noncanonical Wnt pathway might be induced in gastric cancers Turk. J Gastroenterol. 2010;21(3):224–30.Google Scholar
  36. 36.
    Kuang RG, Wu HX, Hao GX, Wang JW, Zhou CJ. Expression and significance of IGF-2, PCNA, MMP-7, and alpha-actin in gastric carcinoma with Lauren classification. Turk J Gastroenterol. 2013;24(2):99–108.PubMedGoogle Scholar
  37. 37.
    Senota A, Itoh F, Yamamoto H, Adachi Y, Hinoda Y, Imai K. Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer. Clin Exp Metastasis. 1998;16(4):313–21.PubMedCrossRefGoogle Scholar
  38. 38.
    Sentani K, Matsuda M, Oue N, Uraoka N, Naito Y, Sakamoto N, et al. Clinicopathological significance of MMP-7, laminin gamma2 and EGFR expression at the invasive front of gastric carcinoma. Gastric Cancer. 2013Google Scholar
  39. 39.
    Yonemura Y, Fujimura T, Ninomiya I, Kim BS, Bandou E, Sawa T, et al. Prediction of peritoneal micrometastasis by peritoneal lavaged cytology and reverse transcriptase-polymerase chain reaction for matrix metalloproteinase-7 mRNA. Clin Cancer Res. 2001;7(6):1647–53.PubMedGoogle Scholar
  40. 40.
    Luo M, Wang XJ, Yang FF. The correlation between the expression of matrix metalloproteinase-7 and the lymph node micrometastases in gastric carcinoma. J Clin Surg. 2013;21(4):269–70.Google Scholar
  41. 41.
    Dong RK, Zhang D, Huang JP, Han MF, Wang QB, Fu J, et al. Expression and relationship between matrix metalloproteinase-7 and E-cadherin in gastric cancer. Cancer Res Clin. 2011;23(1):25–7.Google Scholar
  42. 42.
    Guo SJ, Li YY, Lv JL, Wang FC. Relationship between matrix metalloproteinase-7 mRNA expression and pathological characteristic in gastric carcinoma. J Chin Oncol. 2005;11(1):31–2.Google Scholar
  43. 43.
    Xiang HP, Zhang CL. Expression of MMP-7 gene in gastric cancer tissues and its correlation with metastasis in portal vein nlood and peritoneal cavity. Anhui Med J. 2007;28(3):176–9.Google Scholar
  44. 44.
    Hua H, Li M, Luo T, Yin Y, Jiang Y. Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell Mol Life Sci. 2011;68(23):3853–68.PubMedCrossRefGoogle Scholar
  45. 45.
    Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG. Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol. 2012;181(6):1895–9.PubMedCentralPubMedCrossRefGoogle Scholar
  46. 46.
    Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood). 2006;231(1):20–7.Google Scholar
  47. 47.
    Duffy MJ, McGowan PM, Gallagher WM. Cancer invasion and metastasis: changing views. J Pathol. 2008;214(3):283–93.PubMedCrossRefGoogle Scholar
  48. 48.
    Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer. 2005;8(2):86–94.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.Department of Gastric cancer and soft tissue sarcoma surgeryFudan University, Shanghai Cancer CenterShanghaiChina
  2. 2.Department of Oncology, Shanghai Medical CollegeFudan UniversityShanghaiChina

Personalised recommendations